Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
After finishing at $20.19 in the prior trading day, Surgery Partners Inc (NASDAQ: SGRY) closed at $20.47, up 1.39%. In other words, the price has increased by $1.39 from its previous closing price. On the day, 0.61 million shares were traded. SGRY stock price reached its highest trading level at $20.7387 during the session, while it also had its lowest trading level at $20.23.
Ratios:
Our goal is to gain a better understanding of SGRY by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 11.73 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 15.92. For the most recent quarter (mrq), Quick Ratio is recorded 1.66 and its Current Ratio is at 1.80. In the meantime, Its Debt-to-Equity ratio is 1.86 whereas as Long-Term Debt/Eq ratio is at 1.78.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BofA Securities on December 16, 2024, initiated with a Buy rating and assigned the stock a target price of $30.
On October 14, 2024, UBS started tracking the stock assigning a Buy rating and target price of $38.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 16 ’25 when Anthony Taparo bought 6,463 shares for $19.86 per share.
Bradley Owens bought 9,241 shares of SGRY for $283,652 on Sep 05 ’24. On Sep 04 ’24, another insider, Bane Harrison R., who serves as the National Group President of the company, sold 6,325 shares for $31.11 each. As a result, the insider received 196,742 and left with 48,236 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SGRY now has a Market Capitalization of 2602023424 and an Enterprise Value of 7521653248. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.87 while its Price-to-Book (P/B) ratio in mrq is 1.37. Its current Enterprise Value per Revenue stands at 2.52 whereas that against EBITDA is 12.622.
Stock Price History:
The Beta on a monthly basis for SGRY is 2.59, which has changed by -0.3434146 over the last 52 weeks, in comparison to a change of 0.23171377 over the same period for the S&P500. Over the past 52 weeks, SGRY has reached a high of $35.29, while it has fallen to a 52-week low of $19.50. The 50-Day Moving Average of the stock is -9.12%, while the 200-Day Moving Average is calculated to be -23.46%.
Shares Statistics:
The stock has traded on average 1.10M shares per day over the past 3-months and 869450 shares per day over the last 10 days, according to various share statistics. A total of 127.13M shares are outstanding, with a floating share count of 73.96M. Insiders hold about 41.82% of the company’s shares, while institutions hold 68.06% stake in the company. Shares short for SGRY as of 1735603200 were 11005039 with a Short Ratio of 9.99, compared to 1732838400 on 11193553. Therefore, it implies a Short% of Shares Outstanding of 11005039 and a Short% of Float of 19.06.
